ASH HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSIONS: Bleomycin Omission in PET-Negative HL

ASH HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSIONS: Bleomycin Omission in PET-Negative HL

ASH HIGHLIGHTS 2024 ROUNDTABLE DISCUSSIONS
Explore more from your favourite experts – click their name to access their entire library of content.
Icon Chair Speaker

Chair

Dr. Carolyn Owen

Icon Chair Speaker

Speaker

Dr. Kerry Savage

Dr. Anca Prica

Studies / Trials Discussed

Bleomycin Omission in PET-Negative HL

This program has been made possible through unrestricted support from BeiGene, Eli Lilly & Pfizer

Studies/trials discussed:

Bleomycin Omission in PET-Negative HL
Tagged